| Frances Marie Marrero Barrera, MD | |
|
1 Ave Fomento Ste 245, Caguas, PR 00725-5700 | |
| (787) 641-3030 | |
| Not Available |
| Full Name | Frances Marie Marrero Barrera |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 6 Years |
| Location | 1 Ave Fomento Ste 245, Caguas, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275049488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0120X | Ophthalmology - Cornea And External Diseases Specialist | 23272 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Puerto Rico Eye Institute | 2769876028 | 4 |
News Archive
Cardiologists at Temple University Hospital are working with area primary care physicians to help educate patients who are at moderate-to- high risk for heart attack about new guidelines for lowering cholesterol.
Victims of severe traumatic elder abuse are more likely to be female, suffer from a neurological or mental disorder, and to abuse drugs or alcohol, according to research published in the March issue of the Journal of the American Geriatrics Society.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
According to a report published in the Medical Journal of Australia (MJA) yesterday, on average one child in the Queensland mining town of Mount Isa will exceed safe lead levels every nine days. The report also claimed that not enough was done to address the problem. MP Betty Kiernan has defended the measures taken to address this serious problem.
› Verified 3 days ago
| Entity Name | Puerto Rico Eye Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548723158 PECOS PAC ID: 2769876028 Enrollment ID: O20220302001649 |
News Archive
Cardiologists at Temple University Hospital are working with area primary care physicians to help educate patients who are at moderate-to- high risk for heart attack about new guidelines for lowering cholesterol.
Victims of severe traumatic elder abuse are more likely to be female, suffer from a neurological or mental disorder, and to abuse drugs or alcohol, according to research published in the March issue of the Journal of the American Geriatrics Society.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
According to a report published in the Medical Journal of Australia (MJA) yesterday, on average one child in the Queensland mining town of Mount Isa will exceed safe lead levels every nine days. The report also claimed that not enough was done to address the problem. MP Betty Kiernan has defended the measures taken to address this serious problem.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frances Marie Marrero Barrera, MD 1 Ave Fomento Ste 1, Caguas, PR 00725-5700 Ph: (787) 641-3030 | Frances Marie Marrero Barrera, MD 1 Ave Fomento Ste 245, Caguas, PR 00725-5700 Ph: (787) 641-3030 |
News Archive
Cardiologists at Temple University Hospital are working with area primary care physicians to help educate patients who are at moderate-to- high risk for heart attack about new guidelines for lowering cholesterol.
Victims of severe traumatic elder abuse are more likely to be female, suffer from a neurological or mental disorder, and to abuse drugs or alcohol, according to research published in the March issue of the Journal of the American Geriatrics Society.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.
Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.
According to a report published in the Medical Journal of Australia (MJA) yesterday, on average one child in the Queensland mining town of Mount Isa will exceed safe lead levels every nine days. The report also claimed that not enough was done to address the problem. MP Betty Kiernan has defended the measures taken to address this serious problem.
› Verified 3 days ago
Dr. Cesar R. Quinones, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Street Lopez Flores #5, Suite 1 Urb. Paradis, Caguas, PR 00726 Phone: 787-745-1910 Fax: 787-743-8974 | |
Dr. Emilio A Baez Rivera, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 81 Ave Luis Munoz Marin Ste 201, Caguas, PR 00725 Phone: 787-258-2237 Fax: 787-747-0964 | |
Maria Gabriela Velazquez Lamela, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Plaza Bairoa, Pr #1 Ave Sakura, Caguas, PR 00725 Phone: 787-641-3030 Fax: 787-641-3031 | |
Mrs. Rosana Rosado, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Ave. Gautier Benitez Oficina 404, Consolidated Medical Plaza, Caguas, PR 00725 Phone: 787-745-0115 Fax: 787-745-0115 | |
Guillermo A Torres Cabrera, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Munoz Rivera Ave #1a, Centro Ambulatorio Hima Suite 401,, Caguas, PR 00726 Phone: 787-743-0333 Fax: 787-743-5845 | |
Dr. Grimanessa Cruz-cabanas, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Hima Plaza Uno, 500 Ave Degetau, Suite 411, Caguas, PR 00725 Phone: 787-743-3886 Fax: 787-286-5180 |